Eigenvalue Attraction in Real Matrix Models of Open Quantum Systems, Biophysical Systems, and Parity-Time Symmetric Materials
Biophysical Reviews and Letters · 07.11.2026 · 1-41
DOI: 10.1142/s1793048026310028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Reviews and Letters, online erschienen am 07.11.2026. Verfasst von Pete Rigas. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
In this paper, we investigate eigenvalue attraction appearing in real matrix models of Open quantum systems, Biophysical systems and Parity-Time symmetric materials. To determine whether an eigenvalue and its complex conjugate collide, and hence attract, through an eigenvalue attraction mechanism that has previously been characterized by [R. Movassagh, Eigenvalue attraction, J. Stat. Phys. 162(3), 615–643 (2016), doi:10.1007/s10955-015-1424-5], we derive expressions for the second time derivative of eigenvalues. Such a derivative is not only dependent upon contributions from inertial forces but also from attraction between an eigenvalue and its complex conjugate and the remaining eigenvalues in the spectrum. To demonstrate that computations underlying the derivatives of eigenvalues are well posed, we characterize exceptional points at which degeneracies are encountered.
Zitieren
APA
Rigas, P. (2026). Eigenvalue Attraction in Real Matrix Models of Open Quantum Systems, Biophysical Systems, and Parity-Time Symmetric Materials. Biophysical Reviews and Letters, 1-41. https://doi.org/10.1142/s1793048026310028
Vancouver
Rigas P. Eigenvalue Attraction in Real Matrix Models of Open Quantum Systems, Biophysical Systems, and Parity-Time Symmetric Materials. Biophysical Reviews and Letters. 2026:1-41. doi:10.1142/s1793048026310028
BibTeX
@article{Rigas2026,
author = {Rigas, Pete},
title = {Eigenvalue Attraction in Real Matrix Models of Open Quantum Systems, Biophysical Systems, and Parity-Time Symmetric Materials},
journal = {Biophysical Reviews and Letters},
year = {2026},
pages = {1--41},
doi = {10.1142/s1793048026310028}
}
EUVIMED